DMD (dystrophin; HGNC:2928, NCBI Gene ID 1756) is a human locus mapped to chromosome band Xp21.2-p21.1 that encodes full-length muscle dystrophin Dp427m (3,685 aa; 427 kDa) & shorter tissue isoforms. DMD acts in dystrophin-associated glycoprotein complex (DGC) sarcolemmal mechanical stabilization, together with Antisense Oligonucleotides (ASOs), Messenger RNA (mRNA), and Small Nuclear RNA (snRNA) & Splicing. Dystrophin, supports muscle structure; linked to muscular dystrophy.
Out-of-frame mutations cause Duchenne muscular dystrophy; in-frame cause Becker; target of exon-skipping ASOs & micro-dystrophin AAV
Gene Structure & Expression
Genomic Organization & Cytogenetic Locus: The largest known human gene, spanning ~2.22 megabases across 79 exons at chromosome Xp21.2-p21.1 (~0.1% of the entire human genome, requiring ~16 hours for RNA polymerase II to transcribe a single primary pre-mRNA), driven by seven tissue-specific promoters that produce full-length 427 kDa isoforms (Dp427m in muscle, Dp427c in cortex, Dp427p in Purkinje cells) and shorter internal isoforms (Dp260, Dp140, Dp116, Dp71).
Cellular & Tissue Expression Profile: Dp427m localizes at the cytoplasmic face of the sarcolemma (costameres) in all skeletal muscle fibers, cardiac myocytes, and smooth muscle cells, bridging the intracellular cytoskeleton to the extracellular basal lamina.
Molecular Function & Pathways
Biochemical & Physiological Mechanism: Its N-terminal tandem calponin-homology domain binds filamentous gamma-actin, its central rod domain of 24 spectrin-like repeats and four flexible hinges absorbs contractile shear forces like a molecular shock absorber, and its cysteine-rich and C-terminal domains bind beta-dystroglycan, syntrophins, and alpha-dystrobrevin within the dystrophin-associated glycoprotein complex (DGC) to prevent contraction-induced sarcolemmal micro-tears and pathological Ca2+ influx.
Clinical & Therapeutic Significance
Human Genetic Variants & Disease Phenotypes: According to the Monaco reading-frame rule, hemizygous deletions, duplications, or point mutations that disrupt the open reading frame eliminate dystrophin and cause severe Duchenne muscular dystrophy (DMD), whereas mutations that preserve the reading frame yield internally shortened, partially functional dystrophin and cause milder Becker muscular dystrophy (BMD).